- Previous Close
0.3504 - Open
0.3511 - Bid --
- Ask 0.3601 x 200
- Day's Range
0.3500 - 0.3599 - 52 Week Range
0.2400 - 1.7900 - Volume
102,130 - Avg. Volume
481,555 - Market Cap (intraday)
7.387M - Beta (5Y Monthly) 1.72
- PE Ratio (TTM)
-- - EPS (TTM)
-1.5200 - Earnings Date Jun 25, 2025 - Jun 30, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
3.88
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device for cancer and life-threatening viral infections and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.
www.aethlonmedical.comRecent News: AEMD
View More
Performance Overview: AEMD
Trailing total returns as of 4/7/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AEMD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AEMD
View MoreValuation Measures
Market Cap
7.23M
Enterprise Value
3.13M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
1.67
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-72.47%
Return on Equity (ttm)
-160.04%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-9.56M
Diluted EPS (ttm)
-1.5200
Balance Sheet and Cash Flow
Total Cash (mrq)
4.83M
Total Debt/Equity (mrq)
16.72%
Levered Free Cash Flow (ttm)
-5.54M